Drug Abuse Prevention Intervention Research (R01)

The summary for the Drug Abuse Prevention Intervention Research (R01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Other Agency, which is the U.S. government agency offering this grant.

Drug Abuse Prevention Intervention Research (R01): Grants Notice

Federal Grant Title:	Drug Abuse Prevention Intervention Research (R01)
Federal Agency Name:	Other Agency
Grant Categories:	Other
Type of Opportunity:	Information not provided
Funding Opportunity Number:	PA-07-110
Type of Funding:	Information not provided
CFDA Numbers:	93.279
CFDA Descriptions:	Drug Abuse and Addiction Research Programs
Current Application Deadline:	No deadline provided
Original Application Deadline:	No deadline provided
Posted Date:	No date given
Creation Date:	No date given
Archive Date:	No date given
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	Information not provided

Applicants Eligible for this Grant: Information not provided
Grant Announcement Contact: Information not provided
Similar Government Grants: • Using Neuromodulation to Characterize the Continuum of Pathophysiology Between Substance U...; • Education Activities for Responsible Analyses of Complex, Large-Scale Data (R25- Clinical ...; • Research on the Neuro-Immune Axis in the context of HIV and Substance Use (R01 Clinical Tr...; • Research on the Neuro-Immune Axis in the Context of HIV and Substance Use (R21 Clinical Tr...; • Developing Digital Therapeutics for Substance Use Disorders (UG3/UH3 Clinical Trial option...; • NIDA Phase II Small Business Innovation Research (SBIR [R44]) Competing Renewal Awards; • Drug Abuse Aspects of Hiv/Aids and Other Infections; • Epidemiology of Drug Abuse
More Grants from the Other Agency: • This is a test opporturtunity. Please DO NOT submit.; • TEST-TEST-TEST-02-05-10; • Test